Home › Studies › PRJNA928311
PRJNA928311 SRP419200

Ileostoma probiotic intervention, Groningen

Probiotics supplementation to ileostoma bacterial community cause dynamic increase in their resistance to perturbations and metabolic utilization

53 samples from adult ileostoma subjects in Groningen, Netherlands, studying effects of probiotic supplementation (Ecologic825) on small intestinal microbiota; intervention study design. machine-written summary

53 samples · 53 runs · NL · Age unknown · 2024 · 0.42 Gbp / sample

Sources
✓Sequence archive 366○Abstract / description✓Full text 106○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive366 sample values (collection date, country, intervention, location region, medication, medication detail, subject id, timepoint)
○ Abstract / descriptionread; no usable statement
✓ Full text106 sample values (health condition, health condition detail) · PMC10332219
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention · arms resolved

before · no interventionbefore · no interventi29 samplesprobioticprobiotic24 samples
single arm: samples before and on the intervention

6 people have samples in more than one arm.

Probiotic (live microorganisms; single strain or mixture) design single_arm_before_after · population other_disease · Probiotic formula Ecologic825 supplementation to ileostoma microbiota

“supplementation with the probiotic formula led to a reduction” — abstract:37417553 (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 country
Age
adult53
Condition
healthy_control53
Country
NL53
Body site
primary53
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)this project, 0.1–0.3 Gbp: 13 samplesall projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 35 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 5 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)all projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 0.42 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal

6 of 6 people sampled more than once (53 samples; median 9, up to 9 per person) · follow-up median 1 d (max 1 d) · median interval between samples 0 d (time from timepoint labels).

Donor1Donor1: day 0Donor1: day 0Donor1: day 0Donor1: day 0Donor1: day 0Donor1: day 0Donor1: day 0Donor1: day 1Donor1: day 1Donor2Donor2: day 0Donor2: day 0Donor2: day 0Donor2: day 0Donor2: day 0Donor2: day 0Donor2: day 0Donor2: day 1Donor2: day 1Donor3Donor3: day 0Donor3: day 0Donor3: day 0Donor3: day 0Donor3: day 0Donor3: day 0Donor3: day 0Donor3: day 1Donor3: day 1Donor4Donor4: day 0Donor4: day 0Donor4: day 0Donor4: day 0Donor4: day 0Donor4: day 0Donor4: day 0Donor4: day 1Donor4: day 1Donor5Donor5: day 0Donor5: day 0Donor5: day 0Donor5: day 0Donor5: day 0Donor5: day 0Donor5: day 1Donor5: day 1Donor6Donor6: day 0Donor6: day 0Donor6: day 0Donor6: day 0Donor6: day 0Donor6: day 0Donor6: day 0Donor6: day 1Donor6: day 10 d0 d0 d1 d1 d

Each row is one person (6 shown); dots are samples at days since that person's first sample.

How longitudinal and relatedness information is derived

Community composition
Klebsiella 18.1%Escherichia 16.3%Bacteroides 10.8%Lactococcus 9.8%Enterococcus_A 4.7%Enterococcus 4.3%Streptococcus 4.3%Lacticaseibacillus 3.2%Proteus 2.7%Lactiplantibacillus 2.0%Enterococcus_C 1.9%Bifidobacterium 1.7%not assigned to a genus 10.8%other genera 9.4%

Genera, mean relative abundance over 51 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category53 100%
country53 100%53
health_condition53 100%53
subject_id53 100%53
collection_date53 100%53
detailed_location53 100%
health_condition_detail53 100%53
intervention53 100%53
location_region53 100%53
timepoint_label53 100%53
medication24 45%24
medication_detail24 45%24
Papers (1)
  • Dynamic effects of probiotic formula ecologic®825 on human small intestinal ileostoma microbiota: a network theory approach. 2023 PMID 37417553 PMC10332219 own_data
Details
Archive description

The gut microbiota plays a pivotal role in health and disease. The use of probiotics as microbiota targeted therapies is a promising strategy to improve host health. However, dynamic molecular mechanisms are often not elucidated, especially when targeting the small intestinal microbiota. Here we show that supplementation of a probiotic formula (Ecologic825) to the small intestinal bacterial community counteracts the growth of Enterococcaceae, Bacteroidetes and Enterobacteriaceae and reduces ethanol production, leading to major changes in primary metabolism and dynamic resistance to perturbations. The observed alterations were the result of an initial decrease in pH due to increased lactate production by the probiotics, followed by a sharp increase in the levels of butyrate and propionate. As a consequence, probiotics supplementation increased the resistance to perturbation and increased nutrient utilization. Overall, this study shows how probiotic supplementation can affect the small intestinal microbiota and how network theory can be used for the improvement of current and development of novel probiotic therapies.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of age unknown by opus_adjudicated with confidence 0.45. Assay shotgun_dna.

  • host run.host_tax_id · “9606”
  • host run.scientific_name · “human gut metagenome”
  • body site study.title · “ileostoma bacterial community”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN32925669collection_date2022R10.90biosample.attribute:collection_date2022
SAMN32925669countryNLR10.90sample.attr.geo_loc_nameNetherlands: Groningen, Gr
SAMN32925669health_conditionhealthy_controlR30.60paper.fulltext.resultshealthy middle aged-elderly test subjects
SAMN32925669health_condition_detailhealthy middle aged-elderly test subjectsR30.60paper.fulltext.resultshealthy middle aged-elderly test subjects
SAMN32925669interventionno_interventionR10.85biosample.attribute:treatmenttreatment: control
SAMN32925669location_regionGroningenR10.85biosample.attribute:geo_loc_nameNetherlands: Groningen, Gr
SAMN32925680medicationprobiotic_or_prebioticR10.90biosample.attribute:treatmentprobiotic
SAMN32925680medication_detailprobioticR10.90biosample.attribute:treatmentprobiotic
SAMN32925669subject_idDonor1R10.85sample.attr.host_subject_idDonor1
SAMN32925669timepoint_label0hR10.85sample.attr.timepoint0h
Sequencing

53 runs over 53 samples · mean 0.50 Gbp per run (median 0.42 Gbp, total 26.45 Gbp; 53 runs with a base count) · layout PAIRED 53 · platform ILLUMINA 53 · models NextSeq 2000 (53) · 96% of runs with a Sandpiper profile · first public 2024-01-19

Authors (9)

Jansma J first · Thome NU · Schwalbe M · Chatziioannou AC · Elsayed SS · van Wezel GP · van den Abbeele P · van Hemert S · El Aidy S last

Downloads

PRJNA928311.csv.gz (2.3 KB) · parquet (72.2 KB) — all 53 samples, every field with route and confidence · PRJNA928311_determinations.csv.gz (3.5 KB) — 472 evidence rows

Samples (53 · every field this project has values for · hover a cell for its source)
Loading the sample table…